Long-term effect of lifestyle intervention on adiposity, metabolic parameters, inflammation and physical fitness in obese children: a randomized controlled trial by Vos, R C et al.
ORIGINAL ARTICLE
Long-term effect of lifestyle intervention on adiposity,
metabolic parameters, inflammation and physical
fitness in obese children: a randomized controlled trial
RC Vos
1,J MW i t
2, H Pijl
3 and ECAM Houdijk
1
1Department of Pediatrics, Juliana Children’s Hospital/Haga Hospital, The Hague, The Netherlands;
2Department of
Pediatrics, Leiden University Medical Center, Leiden, The Netherlands and
3Department of Endocrinology and Metabolism,
Leiden University Medical Center, Leiden, The Netherlands
Background: Behavioral lifestyle intervention, combined with parental involvement, is preferred over standard care or self-help
in childhood obesity. The short-term results of such interventions are promising, but long-term follow-up results are equivocal.
Objective: The objective of the present study was the short (3 months) and long-term (1 and 2 years follow-up) effect
evaluation of a family-based multidisciplinary cognitive behavioral lifestyle intervention on markers of adiposity, metabolism,
inflammation and physical fitness compared with standard care in children with obesity. Also the association between these
outcome variables was determined.
Methods: In this prospective longitudinal clinical trial, obese children were randomly assigned to a 3-month family-based
cognitive behavioral multidisciplinary lifestyle treatment (n¼40; body mass index-standard deviation score (BMI-SDS) 4.2±0.7;
age; 13.3±2.0 years) or to a control group receiving an initial advice on physical activity and nutrition (n¼39; BMI-SDS
4.3±0.6; age 13.1±1.9 years). Anthropometric data, physical fitness, metabolic parameters and inflammatory state were
evaluated at baseline, after intervention (at 3 months) and at 1-year follow-up. At 2-year follow-up, anthropometric data and
physical fitness were measured in the intervention group.
Results: An intervention effect after 1 year was found for adiposity (P¼0.02 for BMI-SDS, P¼0.03 for waist circumference
(WC)-SDS), physical fitness (absolute measured peak value of oxygen uptake (mlmin
 1), standardized for age and gender
(VO2peak-SDS), Po0.01) and insulin resistance (HOMA-SDS, P¼0.04). No significant intervention effect was found for serum
lipid profile, high-sensitive C-reactive protein or for adiponectin. At 2-year follow-up, BMI-SDS in the intervention group (n¼31)
was 3.8±1.2 SDS, significantly less than at baseline (P¼0.02).
Conclusion: A positive 1-year follow-up treatment effect was found for adiposity, physical fitness and glucose homeostasis, but
not for inflammatory markers. There was a significant long-term treatment effect on adiposity, although almost all children
remained obese.
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Introduction
The rapidly increasing prevalence of childhood obesity
observed during the last few decades is assumed to be mostly
the result of changes in environmental factors such as
urbanization, economic growth, technical changes and
culture. These changes have resulted in a large shift, both
in diet and physical activity patterns. The modern ‘Western
diet’ is high in saturated fats, sugar and refined foods, but
low in fiber. Simultaneously a physically active lifestyle has
changed to a more sedentary one.
1
Obesity in childhood tends to persist into adulthood,
2–4
and adult obesity is associated with a higher risk for
developing type 2 diabetes mellitus and cardiovascular
disease.
2,4 Moreover, it has become clear that the adipose
tissue is not only just a fat depot but also an endocrine
organ, producing hormones and inflammation-related
factors that contribute to the chronic state of inflamma-
tion observed in obesity.
5,6 Increased levels of the pro-
inflammatory cytokines such as high-sensitive C-reactive
protein (hsCRP)
7–9 and decreased levels of adiponectin
have been found in children with obesity and insulin
resistance.
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www.nature.com/nutdAn appropriate approach to reduce the obesity-related
health risks is weight loss. Current treatment recommenda-
tions for childhood obesity are lifestyle interventions,
including nutritional and physical activity modification
guided by social cognitive behavioral techniques.
12–14 One
of the central assumptions of a cognitive behavioral
approach is that higher levels of self-confidence increase
the likelihood of lifestyle change.
15 In addition, the life-
style treatment approach has been shown to be equally
successful in both clinical-, community- and school-based
settings.
13,14,16 Moreover, the results of a recent meta-
analysis on lifestyle interventions for obese youth showed
that lifestyle interventions lasting for only a few months can
be expected to produce significant changes in body weight.
13
Also involvement of parent in the treatment of obese
children showed a clearly beneficial effect on treatment
results.
13,14 A better treatment result is found when parents
are educated about healthy nutrition and when training in
behavioral modification was provided.
13 Better treatment
outcomes have also been observed after group therapy
compared with individual treatment only, probably because
of the positive effect of peer support.
17 Furthermore, the
intensity of the program, defined as more contact time with
professional support during the intervention rather than the
total duration of the intervention, appears important for its
efficacy.
18 The results of behavioral lifestyle interventions on
adiposity, metabolism, inflammation and physical fitness
immediately after treatment are promising.
8–10,16,19–23
However, the long-term follow-up effects of such interventions
on obesity and associated comorbidity are uncertain.
18,24
A younger age at start and a substantial decrease of BMI-
SDS (body mass index was expressed as standard deviation
score) during the intervention have been reported to predict
a long-term favorable effect,
25 but more research is needed
to delineate the long-term effects of behavioral lifestyle
interventions.
In this paper, we report on the short (3 months) and long-
term (1 and 2 years) effect of a family-based multidisciplin-
ary lifestyle intervention on markers of adiposity, physical
fitness, metabolic parameters and inflammation compared
with standard care in obese children.
Materials and methods
Study design and setting
We performed a longitudinal prospective randomized clin-
ical trial to evaluate the effects of a family-based multi-
disciplinary lifestyle intervention on various clinical and
physiological features of obese children (as defined by Cole
et al.
26) aged 8–17 years, who were referred to a pediatric
clinic (Juliana Children’s Hospital, the Hague). Children who
met the inclusion criteria were randomized to receive either
a family-based multidisciplinary lifestyle intervention or
standard care. Before randomization, stratification took
place for age (8 to less than 12 years and 12 to less than 17
years), gender (male vs female) and ethnicity (North
European vs others). Normative data for physical fitness,
the inflammation parameters and glucose homeostasis were
collected from a group of healthy children with a normal
body weight recruited by the youth health services (Jeugd
GGD Haaglanden). The study was conducted according to
the ‘Declaration of Helsinki’ and approval was obtained
from the Regional Medical Ethics Committee (Zuid-West
Holland). All parents and children gave their written
informed consent, after they had been given detailed written
explanation regarding the aim of the study, discomfort and
inconvenience associated with it and the option to withdraw
at any time.
Participants
Potential participants were excluded if their knowledge of
the Dutch language, intelligence or social skills were
insufficient to participate in the trial. Other exclusion
criteria were the use of medication that might have an effect
on weight loss, medical comorbidity that could affect
participation or previous enrollment in another cognitive
behavioral treatment program with focus on reducing
obesity. Inclusion criteria were simple obesity, subjects of
8–17 years of age and referral to a pediatrician. From the
108 obese children who met the inclusion criteria, 81 agreed
to participate. Most given reasons of refusal were: (1) not
wanting to take the risk to be randomized to the control
group and consequently wait for a year before starting
treatment; and (2) not wanting to invest into the requested
time for treatment. Overall, 41 children were randomized to
the intervention group and 40 to the control group
(Figure 1). The normal-weight control group consisted of
34 healthy, age-, gender- and ethnicity-matched children
with normal body weight for height.
Family-based multidisciplinary lifestyle intervention
The family-based multidisciplinary lifestyle intervention of
the intervention group consisted of a screening phase of
individual counseling of the children with their parents,
followed by an intensive phase of group sessions during
3 months. The group treatment consisted of seven group
meetings for the children, five separate parent meetings and
one parent meeting together with the children. Meetings of
duration of 2.5h were held once every 2 weeks. The children
meetings were held on weekday afternoons at the hospital.
The five separate parent meetings were provided on week-
days after working hours. Subsequently, refresher follow-up
sessions (2–3 sessions per year) were offered for a total period
of 2 years (Table 1).
The control group received standard care and advice, at
start of the trial, on how to increase their physical activity,
decrease their sedentary activities and improve their eating
behavior according to the Dutch standards for healthy
nutrition. After 1 year, all children in the control group
Effect evaluation of lifestyle therapy in obese children
RC Vos et al
2
Nutrition and Diabeteswere offered the opportunity to participate in the family-
based multidisciplinary lifestyle intervention.
Clinical measures
Measurements were taken before (T1) and after the 3-month
treatments in the intervention group (T2) and after a follow-
up period of 12 months after start (T3). The intervention
group was also evaluated after 24 months (T4). In the
normal-weight control group, tests and blood samples were
determined once.
Weight was measured to the nearest of 0.1kg using an
electronic scale (SECA 911, Vogel & Halke, Hamburg,
Germany) and height to the nearest of 0.1cm with
a stadiometer (Holtain Limited, Crymych, Dyfed, UK) in
underwear and barefoot by an experienced assistant. The
BMI was calculated as weight/height squared (kgm
 2).
Subjects were classified as obese using BMI gender- and
age-specific international cutoff levels.
26 BMI was expressed
as standard deviation score (SDS) for Dutch references.
27
The 1980 reference data for weight and height were used to
obtain a realistic view on the degree of obesity without the
data being biased by the increased prevalence rate of
childhood obesity. Waist circumference (WC, in cm) was
measured with an anthropometric tape midway between the
lower rib margin and the iliac crest at the end of gentle
expiration and expressed as SDS (WC-SDS).
28 The WC/height
(both in cm) ratio (WC/Ht) was used as an additional
measure for increased health risk. Blood pressure was
determined in a relaxed sitting position; measurement was
carried out with an electronic device (Criton Dinamap,
No. 8100, GE Healthcare, Hoevelaken, the Netherlands), in
duplicate; the last measurement was used for further
analysis.
Ethnicity was determined according to self-reports given
by the parents. For this analysis, subjects were classified as
‘Northern European’ (38% of the total sample) when both
parents reported the Northern-European ethnicity, and
‘others’ (62%) when one or both parents reported another
ethnicity. Subjects in the ‘others’ group were mainly
of Hindustani (28% of total sample) and Mediterranean
(28% of total sample) origin.
Pubertal development was recorded by the pediatrician
according to Tanner.
29 Breast development in girls and
genital development in boys was used for pubertal classifica-
tion into two groups: prepubertal (breast or genital stage p1)
and pubertal (stages 2–5).
Voluntary maximal exercise test
The physical fitness of the children was determined by
a voluntary maximum exercise test on a treadmill
using breath-by-breath analysis and plots according to
Wasserman.
30
The exercise test consisted of three stages; a reference
stage (2-min rest before the exercise test), the test stage
(the exercise test until voluntary exhaustion occurred) and a
recovery stage (2-min recovery measurement in rest after the
exercise test). The test stage started with a velocity of
4kmh
 1 and an angle of 0% during 1min. Every minute
the velocity increased by 0.5kmh
 1 and the angle by 2%,
until voluntary exhaustion occurred. During the test, all
subjects were verbally encouraged to perform maximally.
At the end of the test, the children were asked to grade the
level of exhaustion using the Borg scale
31 and explain their
reason for ending the test.
Peak values were based on the heart rate and a respiratory
exchange ratio of 41.0 between oxygen uptake (VO2) and
carbohydrate output. This level is, in children, equivalent
with the anaerobic threshold at which point exhaustion
starts.
32 This latter criterion is a generally accepted approach
to establish if peak values are reached. The physical fitness
was determined from the absolute measured peak value of
VO2 (mlmin
 1), standardized for age and gender (VO2peak-
SDS). Also the peak VO2 adjusted for body weight was
determined by dividing the absolute VO2 by body weight
(mlmin
 1 per kg) and standardized it for age and gender
(VO2peak-SDS-kg). In obese subjects, it is common to use this
latter approach for physical fitness because the peak value
of the absolute VO2 is biased, as obese subjects usually also
have a large absolute amount of muscle weight compared
with normal-weight peers.
30
108 Assessed for eligibility and invited to participate
Refused consent (n=27)
41 Assigned to Intervention group
36 Were included for analysis at T2
1 Refused 
measures at T1
1 Refused
measures at T1
81 Underwent randomization
40 Assigned to Control group
2 Discontinued
intervention
2 refused
measures at T2
33 Were included for analysis at T2
3 Withdraw for 
measures at T2
3 No measures
at T2
4 lost to follow-up 1 Withdraw
32 Were included for analysis at T3 35 Were included for analysis at T3
31 Were included for analysis at T4
1 lost to follow-up
Figure 1 Flow of participants through study with primary outcome
measurement (BMI-SDS).
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With the subject in supine position, blood samples were
taken by venipuncture after an overnight fast. Before blood
sampling, the fasting state was verbally confirmed by the
participant and the parent(s). After blood sampling, serum
samples of insulin, adiponectin and hsCRP were stored
at  801C before analysis. All blood samples were analyzed in
accredited clinical chemical and hematology laboratories
(Haga Hospital, the Hague and Leiden University Medical
Center, Leiden, The Netherlands).
Glucose was analyzed from lithium heparin plasma by the
glucose oxidase method with the Unicel DxC 800 (Beckman
Coulter, Woerden, the Netherlands). Plasma insulin was
analyzed by a radioimmunoassay method (DSL-1600,
Beckman Coulter; intra-assay coefficient of variation
4.5–8.3%; inter-assay coefficient of variation 4.7–12.2%;
sensitivity 1.3mUml
 1). An index for insulin resistance was
calculated according to the Homeostasis Model Assessment
for insulin resistance (HOMA-IR) formula: (fasting insulin
(mUml
 1) fasting glucose (mmoll
 1))/22.5.
33 Standard
deviation scores for HOMA-IR (HOMA-SDS) were calculated,
based on gender- and age-specific reference values.
34
High-density lipoprotein (HDL) cholesterol level was
analyzed by homogenic enzymatic colorimetry and trigly-
ceride (TG) level by automatized colorimetry, both deter-
mined by bynchon Lx20 Pro/unicel DXC 800 (Beckman
Coulter, Brea, CA, USA).
High-sensitive CRP was analyzed by immunoturbidimetric
assay with Cobas Integra 800 (Roche Diagnostics, Indianapolis,
IN, USA; measuring range 0.15–20.0mgl
 1; sensitivity
0.3mgl
 1 with an inter-assay coefficient of variation
o10%). Adiponectin level was assayed by human adiponectin
Table 1 Characteristics of the family-based multidisciplinary lifestyle intervention
Components Description
Screening phase/
individual counseling
During the screening phase, children and their parents were interviewed at two separate occasions and all interviewed individually by the
multidisciplinary team consisting of a dietitian, a child physiotherapist, a child psychologist and a social worker. Throughout those two
separate meetings, an individual advice was given by the multidisciplinary team, based on the personal situation of each participating
family.
Individual nutritional
advice
A 3-day dietary recall (1 weekend day included) was used by the dietitian to get more insight into the dietary habits of the children.
Information was provided about nutrition and healthy eating behavior according to the traffic-light nutrition list.
40 The traffic-light nutrition
list identifies several main food groups (fruits, vegetables, grains, milk and other dairy products, meat, fish and others). Foods within each
group were color-coded so as to reflect the caloric density per average serving and the Dutch standards for healthy nutrition. The colors are
green for ‘go’, orange for ‘approach with caution’ and red for ‘stop’. The children and parents were involved in planning their own daily
diet for themselves according to the traffic-light nutritional list.
Individual physical
activity counseling
To obtain insight into the child’s general physical activity behavior during the week, a physical activity questionnaire was filled out by a
child physiotherapist. Children were asked how they traveled to school (by foot, by bicycle, by public transportation or by car); physical
fitness classes at school, spare-time sport activities and daily computer and TV use, as well as the duration spend at all these activities were
noted. The information from this questionnaire was used for advice on how to increase and optimize physical activity during everyday life,
such as walking to nearby destinations and reducing sedentary activities (use of computer and TV).
Individual
psychological
counseling
By means of motivational interviewing, the child psychologist helped the children to adapting to a new lifestyle in order to reduce body
weight. Before the child started with the group sessions, individual treatment goals (reduction of 10% of body weight during 3 months
group sessions) were written down in a contract to avoid disappointment.
Children’s group
meetings
Most children with obesity have negative experiences with group activities. For example, they are often not included in social events or
chosen last by sport activities. Therefore, during the first session, much time is spent in getting acquainted with each other. A good group
bond is important for the effect of the treatment because peer support can be very helpful in the treatment of obese children. The main
educational focus of the first two meetings is on nutritional information of a healthy eating pattern and the balance between energy intake
and energy expenditure. During the subsequent meetings, emphasis was put in self-control techniques to cope with difficult situations
(e.g., birthday parties, holidays, lunch breaks at school, being at home alone). Problem solving alternatives are debated (e.g., to avoid a
situation, doing something else, participate in a situation and eat less or participate followed by extra exercise afterward). Other psycho-
educational topics reviewed were self-reward (when coping well with a difficult situation) and self-regulation situations (making a plan how
to integrate healthy behavior in daily living). Stimulus control was also one of the psycho-educational topics (remove unhealthy stimuli at
home, encourage healthy behavior, eat at the dinner table, reduction of environmental stimuli linked to eating). Topics of the last two
meetings were self-image (focus on positive things about themselves) and coping strategies on dealing with teasing.
Parent group
meetings
Topics discussed during the parent meetings included the necessity to change their own lifestyle as well, information on healthy nutrition
(product information, quantities, eating moments, eating locations) and how to help their children. Parents received advice on parenting
styles (boundaries setting with regard to eating behavior, giving positive feedback). During the last meeting, a therapist discusses the role
of all other family members with regard to the treatment in the family (e.g., are other family members supportive, how do they cope with
the lifestyle changes).
Follow-up meetings In order to maintain the newly learned behavior refresh follow-up meetings were given during the first 2 years (2–3 meetings per year). The
child psychologist and the social worker organize these follow-up meetings. The topics repeated were: problem-solving techniques and
relapse-prevention techniques.
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Billerica, MA, USA; intra-assay coefficient of variation
1.78–6.21%; inter-assay coefficient of variation 6.9–9.25%;
sensitivity; 0.78ngml
 1).
Statistical analysis
The analysis was performed using the Statistical Package for
Social Science version 17.0 for Windows (SPSS Inc., Chicago,
IL, USA) and the level of significance was set at Po0.05. Data
were checked for normality before analysis, using descriptive
statistics for skewness, kurtosis and Shapiro–Wilk test.
Fasting insulin was transformed to the natural logarithm.
Data were expressed as mean±standard deviation (contin-
uous variables) and as count and percentage (categorical
variables), unless defined otherwise. One-way analysis of
variance, with Bonferroni correction for multiple testing,
was used to compare the intervention group, obese control
group and normal-weight control group at baseline. Analysis
of variance for repeated measures were used to determine the
mean study parameters over time per group (intervention
and obese control group). The mixed model for repeated
measures was used to determine the effect of intervention
(mean difference between change in the intervention and
control group) over time for all the parameters separately,
adjusted for baseline values. Pearson correlation analysis was
used to assess the associations between the study parameters
at baseline.
Results
Clinical baseline data of 79 obese children (n¼40 in the
intervention group and n¼39 controls) and of 34 normal-
weight children are shown in Table 2. The ratio prepubertal
(Tanner p1) vs pubertal (Tanner 2–5) children was not
significantly different between groups (P¼0.11). At baseline,
the intervention and obese control group did not signifi-
cantly differ in measures of adiposity (BMI-SDS, WC-SDS,
WC/Ht), physical fitness (VO2peak-SDS, VO2peak-SDS-kg),
metabolic parameters (insulin, glucose, HOMA-SDS, HDL,
TG, blood pressure) and inflammation (adiponectin, hsCRP).
At baseline, the parents of both intervention and obese
control group were on average obese as well, showing no
significant difference between groups; BMI of the father
(30.0±7.1 vs 28.4±4.4kgm
 2, respectively) and BMI of the
mother (31.0±9.0 vs 31.2±6.2kgm
 2).
Obese subjects in both the intervention and control
groups showed a significantly (Po0.01) lower physical
fitness (VO2peak-SDS, VO2peak-SDS-kg) and HDL compared
with the normal-weight control group and a higher systolic
blood pressure (P¼0.02 and P¼0.06, respectively). Signifi-
cantly higher fasting insulin (P¼0.03), HOMA-SDS (P¼0.05)
and TG (P¼0.01) were found in the obese intervention
group compared with the normal-weight control group.
During the 3 months intensive phase of the treatment, five
boys and five girls missed two meetings, two boys and five
girls missed one meeting and the remaining children
attended all the group meetings. The short-term (T2 at
3 months) and long-term (T3 after 1-year follow-up) results
are shown in Table 3. On both these study occasions,
measures of adiposity were significantly reduced in the
intervention group, with 10% decreased BMI-SDS and 19%
decreased WC-SDS after 1-year follow-up compared with
baseline. The corresponding values in the obese control
group remained unchanged compared with baseline. After
1-year follow-up, the VO2peak-SDS-kg in the intervention
group had increased by 20%, whereas a reduction of 18% was
observed in the obese control group (Figure 2). Borg scores
for subjective-experienced exhaustion did not significantly
change over time within and between the groups. Measures
for fasting insulin and HOMA-SDS were equal to baseline
values in the intervention group at all study occasions. In the
control group, these measures slightly increased compared
with baseline. Blood pressure decreased more in the inter-
vention group vs baseline values compared with the obese
control group. Lipid profile and inflammatory state in both
the groups remained unchanged.
Table 2 Baseline subject characteristics
Intervention
group
(n¼40)
Control
group
(n¼39)
Normal-weight
control group
(n¼34)
Gender (M/F) 18/22 19/20 14/20
Ethnicity (North European/other) 14/26 11/28 18/16
Puberty (Tanner p1/2–5) 5/35 8/31 7/27
Age (year) 13.3±2.0 13.1±1.9 13.2±2.4
Weight (kg) 85.7±18.4* 85.7±18.6* 51.7±15.1
Height (cm) 161.9±9.7 161.4±11.0 160.2±14.1
BMI (kgm
 2) 32.4±4.7* 32.5±3.9* 19.7±3.3
BMI-SDS 4.2±0.7* 4.3±0.6* 0.5±1.4
WC (cm) 91.1±9.1* 90.5±7.7* 67.0±8.7
WC-SDS 3.7±1.0* 3.7±0.9* 0.3±0.9
WC/Ht 0.56±0.04* 0.56±0.04* 0.42±0.04
VO2peak-SDS 1.7±1.5* 2.2±1.5* 0.0±1.4
VO2peak-SDS-kg  3.0±1.0*  2.8±1.0*  0.8±1.1
Glucose (mmoll
 1)5 . 3 ±0.4 5.2±0.4 5.2±0.5
Insulin (mUl
 1) 19.5±12.2* 14.9±8.0 13.5±9.1
HOMA-IR 4.6±2.9 3.4±1.9 3.2±2.3
HOMA-SDS 2.1±2.3* 1.2±1.3 1.0±2.1
HDL (mmoll
 1)1 . 1 ±0.3* 1.1±0.2* 1.3±0.2
Triglycerides (mmoll
 1)1 . 2 ±1.0* 0.9±0.5 0.7±0.3
Systolic blood pressure (mmHg) 125±13* 126±12* 119±9
Diastolic blood pressure (mmHg) 65±96 5 ±76 7 ±9
Adiponectin (ngml
 1)8 . 6 ±3.8 8.5±3.3 9.7±4.0
hsCRP (mgl
 1)2 . 3 ±2.1 1.8±1.5 0.6±0.9
Abbreviations: BMI, body mass index; BMI-SDS, BMI-standard deviation
score; F, female; HDL, high-density lipoprotein; HOMA-IR, Homeostasis Model
Assessment for insulin resistance; HOMA-SDS, standard deviation scores for
HOMA-IR; hsCRP, high-sensitive C-reactive protein; M, male; VO2peak-SDS-kg,
absolute oxygen uptake by body weight (mlmin
 1 per kg) and standardized it
for age and gender; VO2peak-SDS, absolute measured peak value of oxygen
uptake (mlmin
 1), standardized for age and gender; WC, waist circumfer-
ence; WC/Ht; WC and height ratio; WC-SDS, WC expressed as standard
deviation score. *Significantly different compared with normal weight
control group, Po0.05, tested using ANOVA for comparing between groups.
Results are expressed as mean±s.d.
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after 1-year follow-up is shown in Table 4 as well. In order to
adjust for differences in baseline values between groups,
the baseline values were put in the model as covariates.
The mean differences between the intervention and obese
control group, adjusted for baseline differences, were
statistically significant for all the parameters of adiposity
(BMI-SDS, WC-SDS, WC/Ht), physical fitness (VO2peak-SDS,
VO2peak-SDS-kg) and for HOMA-SDS.
At 2-year follow-up, data on adiposity and physical fitness
were available in 31 children in the intervention group.
Measures for adiposity were similar to T3 (3.8±1.2 BMI-SDS
and 3.2±1.8 WC-SDS). BMI-SDS was still significantly lower
than at baseline in these 31 children (4.2±0.7 SDS, P¼0.02),
but only three children reached a BMI oþ2 SDS. The
physical fitness adjusted for body weight was still 10% better
compared with baseline, but had returned to the T2 value
( 2.7±1.4mlmin
 1 per kg).
Pearson correlation analyses between the study parameters
at baseline are shown in Table 5. A strongly significant
inverse correlation was found between adiposity (BMI-SDS,
WC-SDS, WC/Ht) and VO2peak-SDS-kg. A less pronounced
positive relation was found for all markers for adiposity
with metabolic parameters (fasting insulin, HOMA-SDS, TG,
systolic blood pressure) and hsCRP and an inverse relation-
ship with HDL and adiponectin. Physical fitness, adjusted for
body weight, correlated inversely with metabolic parameters
(fasting insulin, fasting glucose, HOMA-SDS, TG, systolic
blood pressure) and with hsCRP, and correlated positively
with HDL and adiponectin. An inverse correlation was found
between adiponectin and HOMA-SDS and systolic blood
pressure. A positive correlation was found between adipo-
nectin and HDL.
Discussion
Our family-based multidisciplinary lifestyle intervention
showed a positive effect on all the parameters of adiposity
and physical fitness, directly after the intervention and at
follow-up after 1 and 2 years. We also found a modest
but significant intervention effect on insulin resistance
(expressed as HOMA-SDS), that is, unchanged values over
time in the intervention group compared with increasing
values of HOMA-SDS, with persisting adiposity in the obese
Table 3 Outcome parameters at start (T1), after 3 months (T2) and after 12 months (T3) in the intervention and control groups
Intervention group Control group
T1 (n¼40) T2 (n¼36) T3 (n¼32) T1 (n¼39) T2 (n¼33) T3 (n¼35)
BMI-SDS 4.2 (4.0; 4.4) 4.0 (3.7; 4.3) 3.8 (3.4; 4.2) 4.3 (4.1; 4.5) 4.2 (4.0; 4.5) 4.2 (4.0; 4.5)
WC-SDS 3.7 (3.3; 4.0) 3.4 (2.9; 3.8) 3.0 (2.5; 3.6) 3.7 (3.4; 4.0) 3.7 (3.3; 4.1) 3.5 (3.1; 4.0)
WC/Ht 0.56 (0.55; 0.58) 0.55 (0.53; 0.57) 0.53 (0.51; 0.56) 0.56 (0.55; 0.57) 0.56 (0.55; 0.58) 0.56 (0.54; 0.57)
VO2peak-SDS 1.7 (1.2; 2.2) 1.7 (1.2; 2.2) 1.7 (1.1; 2.3) 2.2 (1.7; 2.7) 1.7 (1.2; 2.2) 1.1 (0.6; 1.6)
VO2peak-SDS-kg  3.0 ( 3.3;  2.6)  2.7 ( 3.1;  2.3)  2.4 ( 3.0;  1.9)  2.8 ( 3.2;  2.5)  2.9 ( 3.3;  2.5)  3.3 ( 3.7;  2.9)
Glucose (mmoll
 1) 5.3 (5.1; 5.4) 5.3 (5.1; 5.4) 5.1 (5.0; 5.2) 5.2 (5.1; 5.3) 5.3 (5.0; 5.6) 5.1 (5.0; 5.3)
Insulin (mUl
 1) 19.5 (15.6; 23.4) 17.4 (13.1; 21.7) 20.5 (15.2; 25.9) 14.9 (12.3; 17.5) 20.3 (15.5; 25.0) 18.8 (15.6; 21.9)
HOMA-SDS 2.1 (1.4; 2.9) 1.7 (0.8; 2.5) 2.2 (1.1; 3.3) 1.2 (0.7; 1.6) 2.2 (1.1; 3.4) 1.7 (1.2; 2.3)
HDL (mmoll
 1) 1.1 (1.1; 1.2) 1.1 (1.0; 1.2) 1.1 (1.0; 1.2) 1.1 (1.1; 1.2 1.2 (1.0; 1.3) 1.1 (1.0; 1.2)
TG (mmoll
 1) 1.2 (0.8; 1.5) 1.2 (0.9; 1.5) 1.1 (0.8; 1.4) 0.9 (0.8; 1.1) 1.0 (0.9; 1.2) 1.0 (0.8; 1.3)
SBP (mmHg) 125 (121; 129) 123 (119; 127) 118 (114; 122) 126 (123; 131) 125 (121; 129) 122 (177; 128)
DBP (mmHg) 65 (62; 67) 59 (56; 62) 57 (54; 61) 65 (62; 67) 62 ( 58; 66) 59 (56; 62)
Adiponectin (ngml
 1) 8.6 (7.4; 9.8) 9.2 (7.5; 10.9) 9.4 (7.4; 11.4) 8.5 (7.4; 9.6) 9.1 (7.8; 10.5) 8.9 (7.3; 10.5)
hsCRP (mgl
 1) 2.3 (1.6; 3.0) 1.9 (1.2; 2.6) 1.9 (1.1; 2.8) 1.8 (1.3; 2.3) 2.5 (1.4; 3.7) 2.1 (1.5; 2.8)
Abbreviations: BMI-SDS, body mass index-standard deviation score; DBP, diastolic blood pressure; HDL, high-density lipoprotein; HOMA-SDS, standard deviation
scores for Homeostasis Model Assessment for insulin resistance; SBP, systolic blood pressure; TG, triglyceride; VO2peak-SDS-kg, absolute oxygen uptake
by body weight (mlmin
 1 per kg) and standardized it for age and gender; VO2peak-SDS, absolute measured peak value of oxygen uptake (mlmin
 1), standardized
for age and gender; WC/Ht; waist circumference and height ratio; WC-SDS, WC expressed as standard deviation score. Results are expressed as mean
(95% confidence interval).
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Figure 2 Physical fitness over time in the intervention and control group.
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inflammation showed no significant treatment effect.
The current recommendation for treating childhood
obesity is a multidisciplinary lifestyle intervention with
parental involvement. However, only few programs have
been evaluated and the effect on retaining weight reduction
over time is from small to moderate.
14,16,35 These previous
observations are confirmed by our study, showing a positive
short- and long-term intervention effect on adiposity and
physical fitness. Regarding the short-term treatment effect
on adiposity, our results are similar to those of numerous
previous studies on multidisciplinary lifestyle interventions
in obese children.
16,20,21,24 The follow-up results of such
interventions are more diverse. Although, in agreement with
our findings, some investigators observed still a reduced
BMI-SDS after X1-year follow-up;
14,18 others reported less
favorable follow-up results.
14,21 Nevertheless, on average, the
children were still obese during these follow-up measures.
However, even if such interventions cannot reduce body
weight to the normal range, beneficial results on health can
be accomplished by improving physical fitness, nutritional
habits and coping strategies.
14,35
Table 4 Effect of intervention on markers of adiposity, physical fitness, metabolic parameters and inflammation
Parameters Intervention group Obese control group Difference between two obese groups
Change during
first 12 months
95% CI Change during
first 12 months
95% CI Mean difference adjusted
for baseline (95% CI)
P-value
BMI-SDS  0.4  0.8; 0.0  0.1  0.4; 0.3  0.2 (0.03; 0.42) 0.02
WC-SDS  0.6  1.2;  0.0  0.2  0.7; 0.5  0.4 (0.04; 0.78) 0.03
WC/Ht  0.03  0.06; 0.0  0.01  0.03; 0.0  0.02 (0.001; 0.034) 0.03
VO2peak-SDS 0.0  0.7; 0.8  1.1  1.8;  0.4 0.7 ( 1.1;  0.3) o0.01
VO2peak-SDS-kg 0.5  0.0; 1.1  0.4  0.9; 0.1  0.7 ( 1.1;  0.4) o0.01
Glucose (mmoll
 1)  0.2  0.3; 0.0  0.0 ( 0.3; 0.2) 0.1 ( 0.1; 0.3) NS
Insulin (mUl
 1)1 . 0  7.2; 5.2 3.9  1.1; 8.9  4.0 ( 0.0; 8.0) 0.05
HOMA-SDS 0.1  1.1; 1.1 0.6  0.5; 1.6  0.9 (0.0; 1.7) 0.04
HDL (mmoll
 1)  0.0  0.2; 0.1  0.0  0.2; 0.1  0.03 ( 0.11; 0.06) NS
Triglycerides (mmoll
 1)  0.1  0.5; 0.4 0.1  0.2; 0.4  0.04 ( 0.3; 0.2) NS
SBP (mmHg)  6.6  12.2;  1.0  4.3  10.2; 1.7  2.8 ( 7.0; 1.5) NS
DBP (mmHg)  7.3  11.5;  3.1  5.7  10.0;  1.3  3.2 ( 6.7; 0.4) NS
Adiponectin (ngml
 1)0 . 8  1.5; 3.0 0.4  1.4; 2.3 0.2 ( 0.9; 1.4) NS
hsCRP (mgl
 1)  0.4  1.4; 0.6  0.9  3.2; 1.4  0.8 ( 1.6; 0.1) NS
Abbreviations: BMI-SDS, body mass index-standard deviation score; CI, confidence interval; DBP, diastolic blood pressure; HDL, high-density lipoprotein; HOMA-
SDS, standard deviation scores for Homeostasis Model Assessment for insulin resistance; hsCRP, high-sensitive C-reactive protein; NS, not significant; SBP, systolic
blood pressure; VO2peak-SDS-kg, absolute oxygen uptake by body weight (mlmin
 1 per kg) and standardized it for age and gender; VO2peak-SDS, absolute measured
peak value of oxygen uptake (mlmin
 1), standardized for age and gender; WC/Ht; waist circumference and height ratio; WC-SDS, WC expressed as standard
deviation score.
Table 5 Pearson correlation coefficients of the study parameters at baseline
BMI-
SDS
WC-
SDS
WC/
Ht
VO2peak-
SDS
VO2peak-
SDS-kg
Fasting
glucose
Fasting
insulin
HOMA-
SDS
HDL TG SBP DBP Adiponetine hsCRP
BMI-SDS F
WC-SDS 0.000** F
WC/Ht 0.000** 0.962** F
VO2peak-SDS 0.000** 0.620** 0.487** F
VO2peak-SDS-kg 0.000**  0.737**  0.755**  0.061 F
Fasting glucose 0.032 0.042 0.091  0.158  0.050* F
Fasting insulin 0.000** 0.331** 0.298* 0.040  0.354** 0.304** F
HOMA-SDS 0.189*** 0.217* 0.239*  0.017  0.356** 0.457** 0.433** F
HDL 0.000**  0.466**  0.429**  0.326** 0.001**  0.048  0.223*  0.243** F
TG 0.006** 0.282** 0.249** 0.139  0.021* 0.047 0.366** 0.125  0.370** F
SBP 0.001** 0.398** 0.379** 0.173 0.000* 0.056 0.163 0.213*  0.286** 0.202* F
DBP  0.916 0.054 0.058 0.012  0.855  0.008 0.049 0.079  0.097 0.114 0.269** F
Adiponectin  0.005**  0.272**  0.240*  0.118 0.008**  0.049  0.391**  0.297** 0.323**  0.110  0.220* 0.001 F
hsCRP 0.019*  0.189* 0.242** 0.070 0.000** 0.106  0.008  0.036  0.197*  0.056 0.043 0.109  0.089 F
Abbreviations: BMI-SDS, body mass index-standard deviation score; CI, confidence interval; DBP, diastolic blood pressure; HDL, high-density lipoprotein; HOMA-
SDS, standard deviation scores for Homeostasis Model Assessment for insulin resistance; hsCRP, high-sensitive C-reactive protein; SBP, systolic blood pressure;
VO2peak-SDS-kg, absolute oxygen uptake by body weight (mlmin
 1 per kg) and standardized it for age and gender; VO2peak-SDS, absolute measured peak value of
oxygen uptake (mlmin
 1), standardized for age and gender; TG, triglyceride; WC/Ht; waist circumference and height ratio; WC-SDS, WC expressed as standard
deviation score. *Correlation is significant at 0.05 level (two-tailed); **correlation is significant at 0.01 level (two-tailed); ***correation is 0.189 (P¼0.045).
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way to measure abdominal obesity in adults and children,
and is considered a good indicator of increased metabolic
and cardiovascular risk.
36 According to a previous study,
obese children only had an increased metabolic and
cardiovascular risk compared with normal-weight children
if WC was 490th percentile for age and gender.
36
In addition, among Asian-Indian adolescents, the odds of
having hypertension was more pronounced for increased
WC (5.21; 95% confidence interval (2.14–12.17)) than for
increased BMI (2.90; 95% confidence interval (1.40–6.12)).
37
These findings suggest that during treatment not only a
reduction of BMI-SDS but also a lower WC is important to
establish a beneficial health effect. In this light, our
observations of a significant positive treatment effects on
WC-SDS over time suggest being of greater importance
for improvement of metabolic risk than the reduction of
BMI-SDS.
The beneficial effect of multidisciplinary lifestyle inter-
ventions has been shown to increase when parents are in
some way involved in the intervention.
35 Hence, in order
to achieve a larger treatment effect more emphasis should be
put on motivating the parents to participate and support
their child. The inclusion of the parents in the treatment of
childhood obesity is challenging and health professionals are
often confronted with the lack of parental motivation and
with time constraints of the parents. A further obstacle in the
struggle against childhood obesity is the unrealistic treat-
ment expectations of children and parents. In most studies,
including the current one, children who participate in a
multidisciplinary lifestyle intervention do not lose all their
excess body weight, which most families find difficult to
accept. In order to match expectations with treatment
objectives, it is advised to include an interview with the
child and parents before the program. The purpose of this
interview is to give the family a chance to reflect their
willingness to participate, and discuss achievable realistic
treatment goals. Although we included such an interview in
our program, the child and parents kept focusing on the
absolute amount of body weight loss and found it difficult to
maintain the newly learned lifestyle. Therefore, the period
immediately after the family-based multidisciplinary life-
style intervention is critical for motivating children and their
parents to maintain their changed lifestyle. In this respect, it
may be important to emphasize the favorable effects of the
achieved results in terms of body proportions and metabolic
parameters, rather than the modest weight reduction
obtained by the large majority.
Besides the treatment effect on adiposity, we also found
a significant effect on physical fitness. Our data showed a
significant improvement of fitness over time as opposed to a
significant deterioration of physical fitness when BMI-SDS
was unchanged as seen in the untreated controls. It has been
suggested that the measured absolute peak VO2 in obese
subjects may overestimate the real physical fitness because of
their increased body size.
30 For that reason, the peak VO2
adjusted for body weight, age and gender (VO2peak-SDS-kg) is
often determined to establish a more realistic value for the
physical fitness. In line with earlier studies,
20,38 we found in
our intervention group an unchanged absolute physical
fitness (VO2peak-SDS) over time, whereas physical fitness
adjusted for body weight improved. It appears that absolute
fitness is unaffected by treatment, but both measures for
physical fitness diminished over time in our obese control
group. A stable absolute physical fitness over time has been
suggested to be indicative of training adaptation.
38 As peak
oxygen consumption is directly related to fat-free mass
30 and
subjects’ fat mass, as well as their fat-free mass often decrease
during weight reduction, their absolute physical fitness is
expected to be lower at the end of treatment. An obstacle in
maintaining prolonged weight reduction is, however, that
during weight loss not only body weight decreases but, as a
consequence of the reduced body weight, also the average
daily energy requirements. For prolonged weight reduction,
it will be beneficial to increase physical fitness in order to
prevent the loss of fat-free mass during the weight-loss
period. As we did not measure the fat-free mass in our study,
we were unable to determine a possible positive-training
adaption.
The intervention did not improve insulin resistance, but
still a treatment effect was observed because of the increased
insulin resistance in the control group. In contrast to our
results, previous studies have found a significantly decreased
HOMA-IR and fasting insulin after a lifestyle intervention.
These decreased markers for insulin resistance were found
when clinically significant weight reduction (40.5 BMI-SDS)
occurred,
22 or when BMI and body weight were significantly
reduced.
19 It should, however, be noted that the result of
the latter study was found in only 48 of the 104 children
(47.5%) after completion of the intervention. Therefore, it is
conceivable that, in this study, markers for insulin resistance
were determined only in the children with weight reduction.
The results of the present study confirm the previously
reported association between childhood obesity and the
presence of a pro-inflammatory state, indicated by a
significantly increased hsCRP serum concentration.
7–9 On
the contrary, adiponectin exerts an anti-atherogenic effect
and has previously been found in lower concentrations in
obese compared with normal-weight children.
10,19,22 Adipo-
nectin is also reported to improve insulin sensitivity.
39
In contrast to these earlier studies, we found similar
adiponectin concentrations in the obese and lean children.
A beneficial effect of our family-based multidisciplinary
lifestyle intervention on the inflammatory state was absent.
In earlier studies, a clinically significant BMI-SDS reduction
of 40.5 has been
9,22 associated with a significant increase in
adiponectin and decrease in hsCRP. We speculate that the
modest BMI-SDS reduction after intervention may explain
the absence of a treatment effect on both.
One of the limitations of this study is that our study
population consisted of a clinically referred sample and
thereby may be influenced by selection and referral bias, and
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children in the general population. Treatment-seeking
children with obesity probably experience more disadvan-
tages from their excess body weight and are therefore
perhaps more motivated than their obese peers in the
community. Another limitation of the current study is that
for the follow-up at 2 years, no obese control data were
available, as, for ethical reasons, the obese control group was
offered the same intervention at 1-year follow-up. Finally, it
is unknown what the predictive value is of 2-year follow-up
data for health and behavior in later years.
The strength of this study is thep r o s p e c t i v e ,r a n d o m i z e da n d
controlled study design, with sufficient statistical power, and
the breadth of outcome parameters, including physical fitness.
Since at all points in time, during our study, measurements
were taken by the same person under similar conditions, the
results cannot be biased by inter-observer errors.
In conclusion, our intensive family-based multidisciplin-
ary lifestyle intervention resulted in a modest long-term
reduction of both total and abdominal adiposity accompa-
nied by improved physical fitness, whereas unchanged
adiposity in untreated controls led to decreased physical
fitness and deterioration of insulin resistance state. No effect
was seen on inflammatory markers, probably because almost
all children remained obese.
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